Sugammadex in a morbidly obese patient with prolonged residual neuromuscular blockade caused by vecuronium

Volume: 53 Number: 1 March 1, 2014
  • Karaman Y
  • Karcıoğlu Y
  • Güvenli Y
  • Şahin G
  • Karaarslan S
  • Gönüllü M
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

Sugammadex in a morbidly obese patient with prolonged residual neuromuscular blockade caused by vecuronium

Abstract

Morbid obesity is an important risk factor in anesthesia practice in addition to its adverse effects on health. Prolonged residual neuromuscular blockade which is unresponsive to cholinesterase inhibitors is frequent in morbidly obese patients. In this case report we discuss a patient with morbid obesity who had prolonged residual neuromuscular blockade and was rapidly reversed with sugammadex.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Karaman Y

Karcıoğlu Y

Güvenli Y

Şahin G

Karaarslan S

Gönüllü M

Publication Date

March 1, 2014

Submission Date

March 1, 2014

Acceptance Date

-

Published in Issue

Year 1970 Volume: 53 Number: 1

DOI

https://doi.org/10.19161/etd.344039

IZ

https://izlik.org/JA23SF89UE

Cite

RIS / Bibtex
Vancouver
1.Karaman Y, Karcıoğlu Y, Güvenli Y, Şahin G, Karaarslan S, Gönüllü M. Vekuronyum’a bağlı uzamış rezidüel nöromüsküler bloklu morbid obez hastada sugammadeks. EJM. 2014 Mar. 1;53(1):43-4. doi:10.19161/etd.344039

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.